Dibeta-GB 10 Tablets

babies: not applicable. lactating mother: safe if prescribed.
limited human data suggests that the drug does not show any significant risk to the baby. pregnancy: safe if prescribed, studies have shown limited evidence of side effects.
alcohol: glibenclamide, a metformin tablet, is considered unsafe with alcohol as it may cause severe liver damage. driving: glibenclamide, metformin tablet is used with caution while driving as your blood sugar fluctuations may affect your ability to drive kidney: glibenclamide, metformin tablet is considered unsafe in patients with kidney disease.
consult your doctor before using this medication. liver: glibenclamide, a metformin tablet, is used with caution in patients with severe liver disease.
consult your doctor. dose adjustment is needed based on the severity of the disease..

Hypoglycemia (low blood glucose level) Taste change Nausea Diarrhea Stomach pain Headache Upper respiratory tract infection.

DIBETA GB is a combination tablet used to treat type 2Diabetes mellitus by controlling blood glucose levels by stimulating the pancreas to release a sufficient amount of insulin and lowering the glucose production in the liver, improving the liver insulin sensitivity..

If you miss a dose, Take it as soon as possible. If It is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• DIBETA GB tablet is prescribed to treat type 2Diabetes mellitus. • This medication may cause side effects such as diarrhoea, headache, nausea, vomiting, abdominal pain and dizziness.
• Avoid alcohol consumption while taking this medication. • It may cause hypoglycemia when taken along with other antiDiabetic medicines, alcohol or If you skip or delay taking your meals.
• Inform your doctor about this medication If you have any surgery under a general anaesthetic. • This medication is taken along with food to avoid the risk of having stomach upset.
• Always monitor your blood glucose..

• metformin + acetrizoate sodium: concurrent use of these medications may result in lactic acidosis and acute renal failure. • (glibenclamide + metformin) + somatostatin analogues: concurrent use of these medications may result in impaired glucose regulation.
• glibenclamide + bosentan: concurrent use of these medications may result in an increased risk of liver enzyme elevation. • glibenclamide + acarbose: concurrent use of these medications may result in an increased risk of hypoglycemia.
• glibenclamide + beta-adrenergic blockers: concurrent use of these medications may results in hypoglycemia or hyperglycemia, decreased symptoms of hypoglycemia. • (glibenclamide + metformin) + aspirin: concurrent use of these medications may result in an increased risk of hypoglycemia.
• (glibenclamide + metformin) + fluoroquinolones: concurrent use of these medications may result in blood glucose changes and an increased risk of hypoglycemia. • glibenclamide + desmopressin: concurrent use of these medications may result in an increased risk of hyponatremia..